Why politicians pursue austerity policies that never work.
March/April 2013
Posted inBooks, Government, Magazine, March/April 2013
Charity Case
How taxpayers subsidize failing philanthropies.
Posted inBooks, Government, Health Care, Magazine, March/April 2013
Consequential Drift
The government program where party differences have widened the most, and matter the most, is Medicaid.
Posted inBooks, Law and Justice, Magazine, March/April 2013
Bar Examined
The ever-diminishing advantages of a career in the law versus the undiminished enthusiasm of law schools to mint new attorneys.
Posted inBooks, Magazine, March/April 2013, Politics
Chávez’s Magical Realism
How the Comandante may get the last laugh, even from the grave.
Posted inEconomy, Magazine, March/April 2013
Three Ways to Bring Manufacturing Back to America
The much-ballyhooed “in-sourcing” trend is real enough. But it won’t amount to much unless Washington acts.
Posted inEconomy, Magazine, March/April 2013
A Tale of Two Trade Deals
Never mind Asia, time to pivot to Europe.
Posted inGovernment, Magazine, March/April 2013
Why Agencies Are Always Missing Their Deadlines
Even the best mainstream news stories on the regulatory process tend to mention the number of deadlines an agency has missed as if that’s an indication of its performance. But that kind of coverage is actually an indication of just how little we know about what’s going on behind the scenes. For one, deadlines are […]
Posted inMarch/April 2013
He Who Makes the Rules
Barack Obama’s biggest second-term challenge isn’ guns or immigration. It’s saving his biggest first-term achievements, like the Dodd-Frank law, from being dismembered by lobbyists and conservative jurists in the shadowy, Byzantine rule-making process.
Posted inHealth Care, Magazine, March/April 2013
The Republican Case for Waste in Health Care
Conservatives love to apply “cost-benefit analysis” to government programs—except in health care. In fact, working with drug companies and warning of “death panels,” they slipped language into Obamacare banning cost-effectiveness research. Here’s how that happened, and why it can’t stand.
